Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease
- PMID: 28071824
- DOI: 10.1002/mds.26896
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease
Abstract
Background: Heart rate variability is reduced in idiopathic PD, indicating cardiac autonomic dysfunction likely resulting from peripheral autonomic synucleinopathy. Little is known about heart rate variability in leucine-rich repeat kinase 2-associated PD.
Objectives: This study investigated heart rate variability in LRRK2-associated PD.
Methods: Resting electrocardiograms were obtained from 20 individuals with LRRK2-associated PD, 37 nonmanifesting carriers, 48 related noncarriers, 26 idiopathic PD patients, and 32 controls. Linear regression modelling compared time and frequency domain values, adjusting for age, sex, heart rate, and disease duration.
Results: Low-frequency power and the ratio of low-high frequency power were reduced in idiopathic PD versus controls (P < .008, P < .029 respectively). In contrast, individuals with LRRK2-associated PD were not statistically different from controls in any parameter measured. Furthermore, all parameters trended toward being higher in LRRK2-associated PD when compared with idiopathic PD.
Conclusions: Heart rate variability may remain intact in LRRK2-associated PD, adding to a growing literature supporting clinical-pathologic differences between LRRK2-associated and idiopathic PD. © 2017 International Parkinson and Movement Disorder Society.
Keywords: LRRK2; Parkinson's disease; autonomic dysfunction; heart rate variability.
© 2017 International Parkinson and Movement Disorder Society.
Similar articles
-
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.Clin Auton Res. 2019 Dec;29(6):603-614. doi: 10.1007/s10286-019-00632-w. Epub 2019 Aug 23. Clin Auton Res. 2019. PMID: 31444591
-
Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.Mov Disord. 2016 Jun;31(6):906-14. doi: 10.1002/mds.26591. Epub 2016 Apr 4. Mov Disord. 2016. PMID: 27041685
-
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.Mov Disord. 2016 Aug;31(8):1192-202. doi: 10.1002/mds.26614. Epub 2016 Apr 19. Mov Disord. 2016. PMID: 27091104
-
Clinical Features of LRRK2 Carriers with Parkinson's Disease.Adv Neurobiol. 2017;14:31-48. doi: 10.1007/978-3-319-49969-7_2. Adv Neurobiol. 2017. PMID: 28353277 Review.
-
Leucine-Rich Repeat Kinase 2 in Parkinson's Disease: Updated from Pathogenesis to Potential Therapeutic Target.Eur Neurol. 2018;79(5-6):256-265. doi: 10.1159/000488938. Epub 2018 Apr 27. Eur Neurol. 2018. PMID: 29705795 Review.
Cited by
-
Dysautonomia in Parkinson's Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control.Front Neurosci. 2022 Mar 15;16:842498. doi: 10.3389/fnins.2022.842498. eCollection 2022. Front Neurosci. 2022. PMID: 35368256 Free PMC article.
-
Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease.Clin Auton Res. 2021 Dec;31(6):729-736. doi: 10.1007/s10286-021-00815-4. Epub 2021 Jul 12. Clin Auton Res. 2021. PMID: 34251546
-
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.Clin Auton Res. 2019 Dec;29(6):603-614. doi: 10.1007/s10286-019-00632-w. Epub 2019 Aug 23. Clin Auton Res. 2019. PMID: 31444591
-
Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke.J Transl Med. 2019 Feb 13;17(1):45. doi: 10.1186/s12967-019-1790-x. J Transl Med. 2019. PMID: 30760287 Free PMC article.
-
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism.Int J Mol Sci. 2021 Jan 21;22(3):1045. doi: 10.3390/ijms22031045. Int J Mol Sci. 2021. PMID: 33494262 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical